Stock

The Wall Road Journal: The charges for comparable COVID-19 remedies differ broadly, an evaluation discovered

The cost of similar COVID-19 treatments can vary by tens of thousands of dollars per patient even within the same hospital, according to an analysis of the Wall Street Journal's pricing data, which suggests pandemic care has not escaped the complex economy of the U.S. healthcare system .

One type of patient with some type of severe respiratory disease that is common in patients with COVID-19 is an example of the wide range. Prices for these patients typically ranged from less than $ 11,000 to more than $ 43,000, the analysis found, but some prices could be far higher depending on the severity of the case.

At the New York-Presbyterian Weill Cornell Medical Center in New York, the cost of a patient with severe respiratory disease was approximately $ 55,182 when registered with CVS Health Corp. was insured
Curriculum vitae,
-0.93%
Aetna, according to the hospital. For UnitedHealth Group Inc.
UNH,
+ 0.43%
UnitedHealthcare, the hospital's disclosed rate is $ 64,326 while the price is listed in the hospital data for patients covered by Anthem Inc.
ANTM,
+ 0.84%
Empire Blue Cross Blue Shield was priced at $ 94,357.

The price range shows how very similar hospital services can lead to very different bills. Even during the pandemic and within the same hospital, prices often reflect the leverage an insurer has to gain discounts, as well as the hospital's market power to increase its prices.

An expanded version of this report is available at WSJ.com.

On trend at WSJ.com:

Why COVID-19 shots don't last a lifetime

Mortgage payments are becoming more and more unaffordable

Related Articles